GILEAD SCIENCES INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 119,900 | $13,434,795 | 0.98% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 2, 2025 |
| June 30, 2025 | 119,900 | $13,293,313 | 0.85% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 1, 2025 |
| Sept. 30, 2025 | 119,900 | $13,308,900 | 0.77% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Oct. 31, 2025 |
| Dec. 31, 2025 | 119,900 | $14,716,526 | 0.83% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 13, 2026 |
| March 31, 2026 | 119,900 | $16,710,463 | 1.10% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 1, 2026 |
| June 30, 2026 | 144,900 | $18,306,666 | 1.08% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 31, 2026 |
| Sept. 30, 2026 | 144,900 | $21,597,345 | 1.26% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 2, 2026 |
7 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.